S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction

Stroke

Volumn 28, Issue 10, 1997, Pages 1961-1965

  Büttner, Thomas ^a   Weyers, Stephan ^a   Postert, Thomas ^a   Sprengelmeyer, Reiner ^a   Kuhn, Wilfried ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Blood proteins; Blood brain barrier; Ischemic stroke; Prognosis; S 100 protein

Indexed keywords

PROTEIN S 100;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0342981794     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.10.1961     Document Type: Article

References (33)

1. Endo E, Tanaka T, Isobe T, Kasai H, Okuyama T, Hidaka H. Calcium-dependent affinity chromatography of S-100 and calmodulin antagonist coupled Sepharose. J Biol Chem. 1981;256:12485-12489.
2. Isobe T, Takahashi K, Okuyama T. S-100 protein is present in neurons of central and peripheral nervous system. J Neurochem. 1984;43:1494-1496.
3. Stefansson K, Wollmann RL, Moore BW. Distribution of S-100 protein outside the central nervous system. Brain Res. 1982;234:309-317.
4. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991;22:1254-1258.
5. Hardemark HG, Almqvist O, Johansson T, Pahlman S, Persson L. S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher conical dysfunction. Acta Neurochir (Wien). 1989;99:135-144.
6. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry. 1995;59:103-104.
7. Mokuno K, Kato K, Kawai K, Matuoka Y, Yanagi T, Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci. 1983;60:443-451.
8. Persson L, Hardemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Pahlman S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
9. Sindic C, Chain M, Cambiaso C, Laterre E, Masson P. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1982;45:1130-1135.
10. Takayasu M, Shibuya M, Kanamori M, Suzuki Y, Ogura K, Kagevama N, Umekawa H, Hidaka H. S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 1985;63:417-429.
11. Usui A, Kato K, Murase M, Hotta T, Tanaka M, Takeuchi E, Abe T. Neural-tissue related proteins (NSE, G0 alpha, 28 kDa calbindin-D, S100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest. J Neurol Sci. 1994;123:134-139.
12. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. Stroke. 1996;27:1553-1557.
13. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke. 1985;16:885-890.
14. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
15. Salomon G, Huang YP. Radiologic anatomy of the brain. Berlin, Germany: Springer: 1976.
16. Moulin T, Cattin F, Crepin-Leblond T, Tatu L, Chavot D, Piotin M, Viel JF, Rumbach L, Bonneville JF. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology. 1996;47:366-375.
17. Büttner T, Hornig CR, Busse O, Dorndorf W. CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction. J Neurol. 1986;233:297-303.
18. Busse O, Hoffmann O. CSF lactate and CT findings in middle cerebral artery infarction: a comparative study. Stroke. 1983;14:960-963.
19. Terent A, Ronquist G, Bergström K, Hällgren R, Aberg H. Ischemic edema in stroke: a parallel study with computed tomography and cerebrospinal fluid markers of disturbed brain cell metabolism. Stroke. 1981;12:33-39.
20. Royds J, Timperley W, Taylor C. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change. J Neurol Neurosurg Psychiatry. 1981;44:1129-1135.
21. Thompson EJ. CSF Proteins: A Biochemical Approach. Amsterdam, Netherlands: Elsevier; 1988:117-120.
22. Hardemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig B, Olsson Y, Pahlman S, Persson L. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemi brain damage. J Neurosurg. 1989;71:727-731.
23. Moulin T, Cattin F, Crepin-Lebland T, Tatu L, Chavot D, Piotin M, Viel JF, Rumbach L, Bonneville JF. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology. 1996;47:366-375.
24. Pulsinelli WA, Brierley IB, Plum F. Temporal profile of neuronal damage of transient forebrain ischemia. Ann Neurol. 1982;11:491-498.
25. Heiss WD. Progress in cerebrovascular disease: flow thresholds of functional and morphological damage of brain tissue. Stroke. 1983; 14:329-331.
26. Raichle ME. The pathophysiology of brain ischemia. Ann Neurol. 1983;13:2-10.
27. Ropper AH, Shafran B. Brain edema after stroke: clinical syndrome and intracranial pressure. Arch Neurol. 1984;41:26-34.
28. Pollay M, Roberts PA. Blood brain barrier: a definition of normal and altered function. Neurosurgery. 1980;6:675-685.
29. Katzman R, Clasen R, Klatzo I, Meyer JS, Pappius HM, Waltz AG. Report of Joint Committee for Stroke Resources. IV: brain edema in stroke. Stroke. 1977;8:510-540.
30. Hatashita S, Hoff JT. Brain edema and cerebrovascular permeability during cerebral ischemia in rats. Stroke. 1990;21:582-588.
31. Hornig CR, Busse O, Büttner T, Dorndorf W, Agnoli A, Akengin Z. CT contrast enhancement on brain scans and blood-CSF barrier disturbances in cerebral ischemic infarction. Stroke. 1985;16:268-273.
32. Bounds JV, Wiebers DO, Whisnant JP, Okazaki H. Mechanisms and timing of deaths from cerebral infarction. Stroke. 1981;12:474-479.
33. Castillo J, Davalos A, Nova M. Progression of ischemi stroke and excitotoxic amino acids. Lancet. 1997;349:79-83.